SynBioBeta Speaker
Jerry McLaughlin
CEO
Life Biosciences
May 2026, SynBioBeta
Speaker
Jerry McLaughlin is chief executive officer and director for Life Biosciences, a clinical-stage biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. He has more than 30 years of biopharmaceutical experience, spanning drug discovery, clinical development, and global commercialization. Jerry has contributed to the approval and launch of more than a dozen FDA-approved medicines and has led multiple exits. Most recently, he served as President and CEO of Neos Therapeutics. Previously, he was president and CEO of AgeneBio, a clinical-stage biopharma focused on neurological and psychiatric diseases. He also served in senior management roles at NuPathe, Endo, and Merck & Co. Inc.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
Price increases in
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.